Advertisement

The Role of Anticoagulation in Acute Myocardial infarction

  • Joseph J. Brennan Jr
    Correspondence
    Corresponding Author: Section of Cardiology, 3 FMP, Yale University School of Medicine, 333 Cedar Street P.O. Box 3333, New Haven, CT 06510 Henry S. Cabin, MD
    Affiliations
    Fellow in Cardiology, Yale University School of Medicine, New Haven, Connecticut
    Search for articles by this author
  • Henry S. Cabin
    Affiliations
    Associate Professor of Medicine and Pathology, Yale University School of Medicine; Director of the Coronary Care Unit; and Associate Director of the Cardiac Catheterization Laboratory, Yale-New Haven Hospital, NewHaven, Connecticut
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      Radionuclide techniques for assessing patients with myocardial infarction have evolved from a diagnostic tool to one of quantifying functional myocardial characteristics. These techniques provide measures of regional and global function, myocardial perfusion, and the metabolic integrity of specific regions of the myocardium. These methods are able to quantify the extent of myocardial damage and provide important prognostic information for risk stratification. Newer techniques, particularly those involving metabolic imaging, are being developed to define and quantify myocardium salvaged by acute interventions, and to identify those patients requiring further intervention
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Cardiology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Anticoagulants in Acute Myocardial Infarction:Results of a Cooperative Clinical Trial.
        JAMA. 1973; 225: 724
        • Asinger R.W.
        • Mikell F.L.
        • Sharma B.
        • et al.
        Observations on decreasing left ventricular thrombus with two-dimensional echocardiography: Emphasis on avoidance of false positive diagnosis.
        Am J Cardiol. 1981; 47: 145
        • Asinger R.W.
        • Mikell F.L.
        • Elsperger J.
        • et al.
        Incidence of left ventricular thrombus after acute transmural myocardial infarction: Serial evaluation by two-di-mensional echocardiography.
        N Engl J Med. 1981; 305: 297
        • Bean W.B.
        Infarction of the heart, III. Clinical course and morphological findings.
        Ann Intern Med. 1938; 12: 71
        • RL Cecil
        A Textbook of Medicine.
        in: Edition 10. WB Saunders, Phildelphia1959: 1291
        • Coon W.W.
        • Willis P.W.
        Hemorrhagic complications of anticoagulant therapy.
        Arch Intern Med. 1974; 133: 386
        • DeMaria A.N.
        • Bommer W.
        • Neuman A.
        • et al.
        Left ventricular thrombi identified by cross-sectional echocardiography.
        Ann Intern Med. 1979; 90: 14
        • Douglas A.S.
        Anticoagulant Therapy. Blackwell Scientific, Philadelphia1969: 213
        • Drapkin A.
        • Menskey C.
        Anticoagulant therapy after acute myocardial infarction: Relation of therapeutic benefit to patient’s age, sex and severity of infarction.
        JAMA. 1972; 222: 541
        • Eastman G.L.
        • Cook E.T.
        • Shinn E.T.
        • et al.
        A clinical study of anticoagulants in acute myocardial infarction with particular reference to early heparin therapy.
        Am J Med Sci. 1957; 233: 647
        • Edes T.E.
        • Sunderrajan E.V.
        Heparin-induced hyperkalemia.
        Arch Intern Med. 1985; 145: 1070
        • Emerson P.A.
        • Marks P.
        Preventing thromboembolism after myocardial infarction: Effect of the low dose heparin or smoking.
        Br Med J. 1971; 1: 18
        • Ezekowitz M.D.
        • Wilson D.A.
        • Smith E.O.
        • et al.
        Comparison of indium-Ill platelet scintigraphy and two dimensional echocardiography in the diagnosis of left ventricular thrombi.
        N Engl J Med. 1982; 306: 1509
        • Feigenbaum H.
        Echocardiography Edition 3. Lea & Febiger, Philadelphia1981: 522
        • Forfar J.C.
        A seven-year analysis of haemorrhage in patients on long-term anticoagulant treatment.
        Br Heart J. 1979; 42: 128
        • Friedman M.J.
        • Carlson K.
        • Marcus F.I.
        • et al.
        Clinical correlation in patients with acute myocardial infarction and left ventricular thrombus detected by two-dimensional echocardiography.
        Am J Med. 1982; 72: 894
        • Gallus A.S.
        • Hirsh J.
        • Jutre R.T.
        • et al.
        Small subcutaneous doses of heparin in prevention of venous thrombosis.
        N Engl J Med. 1973; 288: 545
        • Garvin C.F.
        Mural thrombi in the heart.
        Am Heart J. 1941; 21: 713
        • Gifford R.H.
        • Feinstein A.R.
        A critique of methodology in studies of anticoagulant therapy for acute myocardial infarction.
        N Engl J Med. 1969; 280: 351
        • Griffith G.C.
        • Nichols G.
        • Asher J.D.
        Heparin osteoporosis.
        JAMA. 1965; 193: 85
        • Gueret P.
        • Dubourg O.
        • Ferrier A.
        • et al.
        Effects of full-dose heparin anticoagulation on the development of left ventricular thrombosis in acute transmural myocardial infarction.
        J Am Coll Cardiol. 1986; 8: 419
        • Handley A.J.
        • Emerson P.A.
        • Fleming P.R.
        Heparin in theprevention of deep vein thrombosis after myocardial infarction.
        Br Med J. 1972; 2: 436
        • Haugland J.M.
        • Asinger R.W.
        • Mikell F.L.
        • et al.
        Embolic potential of left ventricular thrombi assessed by two-dimensional echocardiography.
        Circulation. 1984; 70: 588
        • Hellenstein H.K.
        • Martin J.W.
        Incidence of thromboembolic lesions accompanying myocardial infarction.
        Am Heart J. 1947; 33: 443
        • Hilden J.
        • Ivensen K.
        • Raaschou F.
        • et al.
        Anticoagulants in acute myocardial infarction.
        Lancet. 1961; 2: 327
        • Honex G.E.
        • Trelove S.C.
        Prognostic factors in myocardial infarction.
        Lancet. 1957; 1: 1155
        • Horgan J.H.
        • Shiel F.O.
        • Goodman A.C.
        Demonstration of left ventricular thrombus by conventional echocardiography.
        J Clin Untrasound. 1976; 4: 285
        • Hurst J.W.
        The Heart, Arteries and Veins Edition 3. McGraw-Hill, New York1974: 1101
        • Hutter A.M.
        • Sidei V.W.
        • Shine K.I.
        • et al.
        Early hospital discharge after myocardial infarction.
        N Engl J Med. 1973; 288: 1141
        • Johannessen K.
        Peripheral emboli from left ventricular thrombi of different echocardiographic appearance in acute myocardial infarction.
        Arch Intern Med. 1987; 147: 641
        • Jordan R.A.
        • Miller D.R.
        • Edwards J.E.
        • et al.
        Thromboembolism in acute and in healed myocardial infarction; I. Intracardial mural thrombosis.
        Circulation. 1952; 6: 1
        • Kakkar V.V.
        • Field E.S.
        • Nicolaides A.N.
        • et al.
        Low doses of heparin in prevention of deep vein thrombosis.
        Lancet. 1971; 2: 669
        • Keating E.C.
        • Gross A.C.
        • Schlamowitz R.A.
        • et al.
        Muralthrombi in myocardial infarctions: Prospective evaluation by two dimensional echocardiography.
        Am J Med. 1983; 74: 989
        • Kelton J.G.
        • Hirsh J.
        Bleeding associated with antithrombotic therapy.
        Semin Hematol. 1980; 17: 259
        • King D.J.
        • Kelton J.G.
        Heparin associated thrombocytopenia.
        Ann Intern Med. 1984; 100: 535
        • Koch-Weser J.
        Coumarin necrosis.
        Ann Intern Med. 1968; 68: 1365
        • Landefeld C.S.
        • Cook E.F.
        • Flatley M.
        • et al.
        Identification and preliminary validation of predictions of major bleeding in hospitalized patients starting anticoagulant therapy.
        Am J Med. 1987; 82: 703
        • Levisman J.A.
        • MacAlpin R.N.
        • Arbasi A.S.
        • et al.
        Echocardiographic diagnosis of a mobile pedunculated tumor in the left ventricular cavity.
        Am J Cardiol. 1975; 36: 957
        • Maurer B.J.
        • Wrax R.
        • Shillingford J.P.
        Frequency of venous thrombosis after myocardial infarction.
        Lancet. 1971; 2: 1385
        • McNeer J.F.
        • Wallace A.G.
        • Wagner G.S.
        • et al.
        The course of acute myocardial infarction: Feasibility of early discharge of the uncomplicated patient.
        Circulation. 1975; 51: 410
        • Miller R.R.
        • Lies J.E.
        • Carretta R.F.
        • et al.
        Prevention of lower extremity venous thrombosis by early mobilization.
        Ann Intern Med. 1976; 84: 700
        • Moser K.M.
        Pulmonary embolism.
        Am Rev Respir Dis. 1977; 115: 829
        • Murray T.S.
        • Cox F.C.
        • Lorimer A.R.
        • et al.
        Leg vein thrombosis following myocardial infarction.
        Lancet. 1970; 2: 792
        • Nax R.M.
        • Barnes A.R.
        Incidence of embolic or thrombotic processes during the immediate convalescence from acute myocardial infarction.
        Am Heart J. 1945; 30: 65
        • Nicolaides A.N.
        • Kakkan V.V.
        • Renney J.T.G.
        • et al.
        Myocardial infarction and deep vein thrombosis.
        Lancet. 1971; 1: 432
        • Nordrehaug J.E.
        • Johannessen K.
        • Von Der Lippe G.
        Use-fulness of high-dose anticoagulants in preventing left ventricular thrombus in acute myocardial infarction.
        Am J Cardiol. 1985; 55: 1491
        • Ports T.A.
        • Cogan J.
        • Schiller N.B.
        • et al.
        Echocardiography of left ventricular masses.
        Circulation. 1973; 58: 528
        • Report of the Working Party of Anticoagulation Therapy in Coronary Thrombosis to the Medical Research Council Assessment of short-term anticoagulant administration after cardiac infarction.
        Br Med J. 1969; 1: 335
        • Richards R.L.
        Anticoagulant therapy in acute myocardial infarction.
        Scott Med J. 1958; 3: 235
        • Selzer A.
        The immediate sequelae of myocardial infarction: Their relation to the prognosis.
        Am J Med Sci. 1948; 216: 172
        • Sharnoff J.G.
        Results in the prophylaxis of postoperative thromboembolism.
        Surg Gynecol Obstet. 1966; 123: 303
        • Sharnoff J.G.
        • DeBiasio G.
        Prevention of fatal postoperative thromboembolism by heparin prophylaxis.
        Lancet. 1970; 2: 1006
        • Simmons A.V.
        • Sheppard M.A.
        • Cox A.F.
        Deep venous thrombosis after myocardial infarction: Predisposing factors.
        Br Heart J. 1973; 35: 623
        • Stratton J.R.
        • Lighty G.
        • Pearlman A.S.
        • et al.
        Detection of left ventricular thrombus by two-dimensional echocardiography; Sensitivity, specificity, and causes of uncertainty.
        Circulation. 1982; 66: 156
        • Stratton J.R.
        • Resnick A.D.
        Increased embolic risk in patients with left ventricular thrombi.
        Circulation. 1987; 75: 1004
      1. Swedish Co-Operative CCU Study. Henning R, Lindman T: Part I. A description of the early stage. Henning R: Part II. The short-term prognosis. Acta Med Scand (Suppl 586) 1975

        • Tulloch J.A.
        • Gilchrist A.R.
        Anticoagulants in treatment of coronary thrombosis.
        Br Med J. 1950; 2: 965
        • Visser C.A.
        • Kan G.
        • Meltzer R.S.
        • et al.
        Embolic potential of left ventricular thrombus after myocardial infarction: A two-dimensional echocardiographic study of 119 patients.
        J Am Coll Cardiol. 1985; 5: 1276
        • Warlow C.
        • Terry G.
        • Kenmore A.C.F.
        • et al.
        A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction.
        Lancet. 1973; 2: 934
        • Weinrich D.J.
        • Burle J.F.
        • Pauletto F.J.
        Left ventricular mural thrombi complicating acute myocardial infarction: Long term follow-up with serial echocardiography.
        Ann Intern Med. 1984; 100: 789
        • Williams H.T.
        Prevention of post-operative deep-vein thrombosis with perioperative subcutaneous heparin.
        Lancet. 1971; 2: 950
        • Wrax R.
        • Maurer B.
        • Shillingford J.
        Prophylactic anti-coagulant therapy in the prevention of calf-vein118 Joseph J. Brennan, Jr and Henry S. Cabin thrombosis after myocardial infarction.
        N Engl J Med. 1973; 288: 815
        • Wright I.S.
        • Marple C.D.
        • Beck D.F.
        Report of the committee for the evaluation of anticoagulants in the treatment of coronary thrombosis with myocardial infarction.
        Am Heart J. 1948; 36: 801